Ketamine IV for the prevention of depression in the elderly: new data

Published Date: 13 Mar 2023

Intravenous (IV) ketamine is effective in adults resistant to depression. The response was similar to that seen in younger patients, two new studies show.

Read Full News

Latest News

US FDA to Review AI-based Tool to Predict Drug-related Liver Damage

The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted ⁠a letter of intent for an artificial intelligence-based drug development tool...

Bundibugyo Ebola Update: Are New Defenses on the Horizon?

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Pediatric Ketamine Sedation Not Tied to Serious AEs

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

NICE Recommends Mepolizumab for Uncontrolled COPD

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Diabetic Ketoacidosis Diagnosed Beyond Lab Criteria

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older Age Tied to Higher CT Positivity in Abdominal Pain

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Todays Updates

Isatuximab Boosts MRD Negativity in Multiple Myeloma

Researchers compare two different treatment regimens in 446 transplant-ineligible patients with newly diagnosed multiple myeloma in a global phase 3 trial.

Novel ADC Improves Survival in Metastatic TNBC

Izalontamab brengitecan extends overall survival among patients with metastatic TNBC, but it’s unclear how the investigational therapy might fit into an evolving treatment landscape.

Proton Therapy Fails to Beat IMRT in Prostate Cancer

For men with localized prostate cancer, proton therapy looks no better than IMRT when it comes to 3-year biochemical progression or GI toxicity.

Fuzuloparib Add-On Improves Metastatic Prostate Cancer rPFS

Researchers track progression-free survival after adding a PARP inhibitor to a standard regimen for metastatic castration-resistant prostate cancer.

Latest News

The U.S. FDA's Center for Drug Evaluation and Research said on Wednesday it has accepted ⁠a letter of intent for an artificial intelligence-based drug development tool...

Global health agencies are accelerating vaccine and therapeutic research because the Bundibugyo Ebola outbreak highlights the absence of approved countermeasures.

Children receiving ketamine sedation in the ED rarely have serious side effects, but risks are slightly higher in those who are older, those with respiratory infections, or those receiving opioids.

Mepolizumab is the second biologic approved for eosinophilic COPD this year, joining dupilumab in offering an alternative to triple therapy alone.

Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.

Older adults visiting the emergency department for abdominal pain have higher risks for CT positivity and hospital admission than younger adults, despite less specific symptoms.

News All Time

Cosmetic-Related Eye Injuries in Kids Up Since 2020

Pediatric eye injuries related to use of cosmetics rose 5.6% from 2020 to 2024, with toddlers most commonly affected and teens showing the largest increases, a new study finds.

AI Beats Physicians AVSs for Hospital Patients

AI over docs: AI-generated after-visit summaries are better than physician-generated ones, physician graders say. Next, patients will judge.

Can Rise of Direct Primary Care Ease Hospital Admissions?

Research has shown direct care may reduce emergency department visit and hospital use, but questions remain about equity.

Hydronephrosis on USG Predicts Stones but May Not Cut CT Use

Hydronephrosis identified on point-of-care ultrasound is linked to higher risks for stone disease and early urologic intervention in suspected renal colic but not with reduced CT use or ED stays.

US Kratom Use Surges 65-Fold in 13 Years

US Kratom use increased more than 65-fold from 2010 to 2023, with a lower incidence of adverse outcomes in states that banned the substance, new research shows.

Apnimed's Sleep Apnea Pill Meets Main Goal in Late-stage Study

Privately held biotech firm Apnimed said on Monday its experimental pill for a sleep disorder met the main ⁠goal in a late-stage trial, potentially offering a convenient...

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

African Public Health Agency Announces New Ebola Outbreak in Congo, 65 Suspected Deaths

Africa's top public health agency said on Friday that there was a confirmed Ebola outbreak in Democratic Republic of Congo's Ituri province, with 65 deaths out of 246...

Rapid Susceptibility Test Falls Short in Bacteremia

Rapid antimicrobial susceptibility testing of blood cultures is not superior to standard testing in patients with gram-negative bloodstream infections, according to the FAST trial.

Socioeconomic Gaps Tied to Concussion-Related ED Visits

Socioeconomic disparities determine where patients seek concussion care and patients' likelihood of receiving follow-up care, a study finds.

Balanced Fluid: No Renal Benefit Over Saline in Septic Shock

In children with septic shock, choosing balanced fluid over saline does not appear to change short-term kidney outcomes or survival.

Is Telemedicine Comparable to In-Person Neurology Care?

Virtual neurology care for new patients is comparable to in-person care, with similar 90-day follow-up rates, ED visits, and hospitalizations, a new study shows.

Regenxbio Shares Sink as Safety Concerns Overshadow Muscle Disorder Therapy Trial Win

Regenxbio said on Thursday that its experimental gene therapy for a muscle-wasting disorder met the main goal ⁠in a late-stage study, but its shares plunged 31% in morning...

US Drug Overdose Deaths Dropped for Third Straight Year in 2025, CDC Data Shows

Drug overdose deaths in the United States fell nearly ⁠14% in 2025, federal estimates showed on Wednesday, marking a third ⁠consecutive year of declines.

Common Practice of DOAC Switching After Stroke Challenged

A multicenter, registry-based cohort study showed no short-term benefit of the common practice of switching anticoagulants after a breakthrough ischemic stroke in patients with atrial fibrillation.

Resistant Gut Bacteria May Flag C difficile Infection Risk

Adults colonised with extended-spectrum beta-lactamase-producing bacteria in the intestinal tract may face higher odds of developing Clostridioides difficile infection.

Recommended News For You

New Standard for Newly Diagnosed Pediatric B-Cell Acute Lymphoblastic Leukemia

Clinical trial is testing whether heavy lifting could combat cancer side effects

Psychedelic Therapy Tied to Reduced Depression, Anxiety.

Photoacoustic spectral analysis for gaining knowledge of the tumor microenvironment.

Belzutifan for Advanced Renal Cell Carcinoma is approved by the FDA.

Climate change is expected to increase the number of suicide deaths

Indoor hydroponic gardening can improve mental health and quality of life for cancer patients

Recommended Articles For You

The Architect's Dilemma: Remodeling the Tumor Microenvironment for a New Era of Cancer Immunotherapy 

Uncovering the Hidden Gallons: How Much Blood Is Inside the Human Body? 

Chloride Test in HCC: Diagnostic Utility, Prognostic Role, and Emerging Insights 

Refractory Iron Deficiency Anemia in a Young Adult: Diagnostic Challenges 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Nuclear missile workers are contracting cancer: They blame the bases

2.

Novel Agent for Chronic GVHD Wins FDA Approval

3.

MET Inhibitor Increases Osimertinib Activity in EGFR+ Advanced NSCLC

4.

Access to GLP-1 medications associated with a lower risk of colorectal cancer in people with type 2 diabetes: JAMA.

5.

Radiation therapy can promote amphiregulin, which increases growth of metastases

1.

The Transformative Power of Genomics in the Diagnosis and Management of Rare Cancers

2.

Minimal Residual Disease Monitoring: Advances, Clinical Relevance, and Guideline-Based Perspectives

3.

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results

4.

The Benefits and Risks of Thrombolytics: A Comprehensive Guide 

5.

Liquid Biopsy in Oncology: Innovations in Cancer Detection, Monitoring, and Clinical Use

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

International Lung Cancer Congress®

3.

Genito-Urinary Oncology Summit 2026

4.

Future NRG Oncology Meeting

5.

ISMB 2026 (Intelligent Systems for Molecular Biology)

1.

Optimizing Treatment Options in Advanced Urothelial Carcinoma

2.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

3.

A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer

4.

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

5.

Efficient Management of First line ALK-rearranged NSCLC - Part III

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot